SC 13G
PUMA BIOTECHNOLOGY, INC.
- Company
- PUMA BIOTECHNOLOGY, INC.
- Filed
- September 1, 2023
- Accession Number
- 0000902664-23-004670
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →